Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback